Dexcom Inc financial data

Symbol
DXCM on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
6340 Sequence Drive, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - Apr 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 272 % +0.44%
Quick Ratio 30 % +22.6%
Debt-to-equity 201 % +35.1%
Return On Equity 29.5 % +113%
Return On Assets 9.77 % +75.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 398 M shares +2.59%
Common Stock, Shares, Outstanding 396 M shares +2.19%
Entity Public Float 49.4 B USD +69.8%
Weighted Average Number of Shares Outstanding, Basic 390 M shares +0.91%
Weighted Average Number of Shares Outstanding, Diluted 417 M shares -0.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.8 B USD +25.8%
Research and Development Expense 528 M USD +13.1%
Operating Income (Loss) 652 M USD +64.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 778 M USD +85.7%
Income Tax Expense (Benefit) 139 M USD +9.79%
Net Income (Loss) Attributable to Parent 639 M USD +119%
Earnings Per Share, Basic 1.65 USD/shares +117%
Earnings Per Share, Diluted 1.54 USD/shares +117%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 851 M USD +36.6%
Accounts Receivable, after Allowance for Credit Loss, Current 979 M USD +53.7%
Inventory, Net 589 M USD +61%
Other Assets, Current 40.4 M USD -6.48%
Assets, Current 4.62 B USD +22.7%
Deferred Income Tax Assets, Net 461 M USD +32%
Property, Plant and Equipment, Net 1.08 B USD +25.6%
Operating Lease, Right-of-Use Asset 68 M USD -12.8%
Intangible Assets, Net (Excluding Goodwill) 123 M USD -24.6%
Goodwill 23.2 M USD -9.73%
Other Assets, Noncurrent 77.7 M USD +37.3%
Assets 6.48 B USD +17.5%
Employee-related Liabilities, Current 111 M USD +16.6%
Contract with Customer, Liability, Current 16.4 M USD +70.8%
Liabilities, Current 1.59 B USD -14.5%
Contract with Customer, Liability, Noncurrent 7.4 M USD -64.3%
Deferred Income Tax Liabilities, Net 4.6 M USD -13.2%
Operating Lease, Liability, Noncurrent 75.8 M USD -15.5%
Other Liabilities, Noncurrent 129 M USD -0.23%
Liabilities 4.24 B USD +29%
Accumulated Other Comprehensive Income (Loss), Net of Tax -37.3 M USD -474%
Retained Earnings (Accumulated Deficit) 1.17 B USD +121%
Stockholders' Equity Attributable to Parent 2.25 B USD +0.62%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.25 B USD +0.62%
Liabilities and Equity 6.48 B USD +17.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 209 M USD +34.6%
Net Cash Provided by (Used in) Financing Activities 4.7 M USD -58%
Net Cash Provided by (Used in) Investing Activities 74.8 M USD
Common Stock, Shares Authorized 800 M shares 0%
Common Stock, Shares, Issued 409 M shares +3.55%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 285 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 852 M USD +36.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.4 M USD +1.64%
Deferred Tax Assets, Valuation Allowance 264 M USD +236%
Deferred Tax Assets, Gross 741 M USD +52.8%
Operating Lease, Liability 101 M USD -12.1%
Depreciation 147 M USD +2.29%
Payments to Acquire Property, Plant, and Equipment 56.9 M USD -23.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 609 M USD +108%
Lessee, Operating Lease, Liability, to be Paid 118 M USD -12.9%
Property, Plant and Equipment, Gross 1.47 B USD +31.1%
Operating Lease, Liability, Current 20.7 M USD -6.76%
Lessee, Operating Lease, Liability, to be Paid, Year Two 24.5 M USD -2%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.3 M USD -1.13%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -41.8 M USD -349%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.7 M USD -17.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 24.4 M USD +2.09%
Deferred Tax Assets, Operating Loss Carryforwards 18.1 M USD -61%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -4.3 M USD -119%
Current Income Tax Expense (Benefit) 224 M USD +214%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 59.4 M USD +14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 19.2 M USD -18.3%
Operating Lease, Payments 28.1 M USD +8.08%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 18.1 M USD -30.7%
Current Federal Tax Expense (Benefit) 149 M USD +357%
Amortization of Intangible Assets 8.1 M USD +8%
Depreciation, Depletion and Amortization 52.5 M USD +26.2%
Deferred Tax Assets, Net of Valuation Allowance 477 M USD +17.3%
Share-based Payment Arrangement, Expense 155 M USD +16.6%
Deferred State and Local Income Tax Expense (Benefit) 14.6 M USD
Interest Expense 20.3 M USD +9.14%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%